Business Description
Immunic Inc
NAICS : 541714
SIC : 2834
ISIN : US92847R1041
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 83.45 | |||||
Equity-to-Asset | 0.74 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | -0.01 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 10.5 | |||||
3-Year EPS without NRI Growth Rate | 9.1 | |||||
3-Year FCF Growth Rate | 18.4 | |||||
3-Year Book Growth Rate | -56 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 30.17 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 76.27 | |||||
9-Day RSI | 65.3 | |||||
14-Day RSI | 60.42 | |||||
6-1 Month Momentum % | -6.46 | |||||
12-1 Month Momentum % | -18.07 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.75 | |||||
Quick Ratio | 3.75 | |||||
Cash Ratio | 3.51 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -28.7 | |||||
Shareholder Yield % | 0.18 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -162.21 | |||||
ROA % | -118.93 | |||||
ROIC % | -2549.58 | |||||
3-Year ROIIC % | 162.3 | |||||
ROC (Joel Greenblatt) % | -5404.94 | |||||
ROCE % | -157.61 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 2.11 | |||||
Price-to-Tangible-Book | 2.09 | |||||
EV-to-EBIT | -0.59 | |||||
EV-to-EBITDA | -0.59 | |||||
EV-to-FCF | -0.76 | |||||
Price-to-Net-Current-Asset-Value | 2.15 | |||||
Price-to-Net-Cash | 2.37 | |||||
Earnings Yield (Greenblatt) % | -169.49 | |||||
FCF Yield % | -54.21 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Immunic Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -1.389 | ||
Beta | 1.76 | ||
Volatility % | 63.77 | ||
14-Day RSI | 60.42 | ||
14-Day ATR (€) | 0.051789 | ||
20-Day SMA (€) | 1.2857 | ||
12-1 Month Momentum % | -18.07 | ||
52-Week Range (€) | 0.8905 - 2.254 | ||
Shares Outstanding (Mil) | 90.08 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Immunic Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Immunic Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Immunic Inc Frequently Asked Questions
What is Immunic Inc(FRA:10VA)'s stock price today?
When is next earnings date of Immunic Inc(FRA:10VA)?
Does Immunic Inc(FRA:10VA) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |